COVID-19 is an infectious disease caused by a newly discovered coronavirus named SARS-CoV2.
Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment. Elder people, and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness.
Sansure COVID-19 diagnostic solutions are used to directly detect the presence of viral RNA, which will be detectable in patients before antibodies form or symptoms of the disease are present, which means the test results can tell whether or not that someone gets virus very early on in their illness.
PERFORMANCE
One-tube/fast release technology
Up to 96 samples at one time
Simple operation process, less specialist training
Room temperature lysis, less contamination
Sampling types : nasopharyngeal swab, oropharyngeal swab, alveolar lavage fluid, sputum, serum, whole blood ,Feces
Enhance large-scale screening efficiency
Internal control: human housekeeping gene RNase P
PARAMETERS
Extraction Platform : One-tube fast release technology / Advanced magnetic beads technology
Internal Control - : Rnase P gene
PCR Instrument - : SLAN-96P, ABI7500, QuantStudio 5 , Roche 480, MA-6000, Portable Molecule Workstation ( S-Q31A )
Sensitivity : 200copies/mL
Spec. : 24T/48T